Abstract

Female Thamnophis sirtalis were administered intraperitoneal implants of either estradiol 17β (E2), testosterone (T), 5α-dihydrotestosterone (DHT), or empty silastic capsules for 3 weeks. Plasma levels of E2 and T, measured by specific radioimmunoassay, were significantly elevated in E2 and T-implanted females when compared to controls. T-implanted females did not have elevated circulating E2 levels, suggesting that E2 in the plasma normally is not derived from peripheral conversion of T to E2. Implantation of DHT did not significantly change circulating levels of E2, T, or DHT. All three sex steroid-treated groups of animals had increased oviductal mass compared to controls, while hepatic mass of only E2-treated animals was significantly greater. None of the steroid treatments influenced ovarian mass. Oviductal epithelial cell height and area were greater in the three steroid-treated groups. Testosterone increased myometrial area while DHT drastically altered oviductal morphology. Hepatic cell area and number increased significantly in E2-treated females. However, a small increase in both hepatic cell area and number was noted in T- and DHT-treated females as well. These results suggest that androgen in both an aromatizable and non-aromatizable form can affect the oviduct of females but that the liver primarily responds to estrogenic steroids. © 1992 Wiley-Liss, Inc.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call